you may also wish to take the time to go back, and review exactly what was and was not said by SRPT management at their Perth presentation. Your recollection of what was presented with regards to cardiac and lung STABILIZATION is flawed if I'm not mistaken. The following is a quote from a post by Jordan.marx, describing what was going on in Perth.
" Some of the arguments that have been used to justify staying away from the stock have been neutralized. Such as what happened to the twins and their decline, and then later pulmonary and cardiac stabilization. It appears the results are really great, and the two kids that everyone thought didn't do well, actually stabilized. It appears that Sarepta has a wonderful technology on its hands. With these added details concerning the phase IIb results, accelerated approval is more likely. A small company with an amazing technology. Something to be long about. I don't pretend to understand the science, (I have my Molecular Biologist wife for that), but I do like the sound of an amazing technology in the hands of a small company with a lot of potential growth in the future. I am sure I am missing some points that some of the more scientific folks on this message board can elaborate on further."
I'm not sure what your agenda is exactly, but regardless, facts should help.